SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...

As Cosmoprof Worldwide Bologna wraps its 57th edition this week, AI, biotech, and venture capital are converging on a sector that has long outpaced the attention it receives from institutional ...

BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.

Swiss drugmaker Novartis will buy California-based ‌biotech company Excellergy in a deal worth up to $2 billion, it said on ...

The Swiss pharma giant is betting on a next-generation allergy treatment that may prove to work faster and better than ...

Some investors and analysts believe the pharma’s $6.7 billion offer is justified given Terns’ recent stock run. Others are ...

Attend or sponsor our commercial real estate event in San Francisco: Bay Area Life Sciences & Biotech Conference.

A neurotechnology startup aiming to treat chronic pain and neurological disorders won the 15th annual Massachusetts Medical ...

You might be surprised to hear this, but off-the-shelf CAR-T therapies for cancer are still a thing. We preview an ...

Adaptive Biotechnologies, a leader in immune-driven diagnostics, saw a notable insider sale amid ongoing innovation in ...

Preview this article 1 min The St. Louis Business Journal staff has compiled informational listings of major workforce ...

Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed ...